Literature DB >> 30279299

Recannulation of Distal Radial Artery for Staged Procedure After Successful Primary Percutaneous Coronary Intervention.

Yongcheol Kim, Myung Ho Jeong1, Kirill Berezhnoi, Sang Yeub Lee, Min Chul Kim, Doo Sun Sim, Young Joon Hong, Ju Han Kim, Youngkeun Ahn.   

Abstract

There are limited data regarding the snuffbox approach. Our experience highlights the feasibility of snuffbox approach as the access route for primary PCI and recannulation of distal radial artery for staged PCI.

Keywords:  acute coronary syndrome; cardiac imaging; myocardial infarction; radial artery

Mesh：

Year:  2018        PMID： 30279299

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN： 1042-3931            Impact factor:   2.022


  4 in total

1.  Successful primary percutaneous coronary intervention in patient with ST-segment elevation myocardial infarction via left snuffbox approach: Patient advantages.

Authors:  Yongcheol Kim; Myung Ho Jeong; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn
Journal:  Cardiol J       Date:  2019       Impact factor: 2.737

2.  Snuffbox Approach for Coronary Chronic Total Occlusion Intervention Using a 7-French Sheath.

Authors:  Yongcheol Kim; Dae Yong Hyun; Kyung Hoon Cho; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong
Journal:  Chonnam Med J       Date:  2019-09-24

3.  Successful Drug-Eluting Stent Overexpansion with Intravascular Ultrasound Guidance for Left Main Bifurcation Lesion Via Left Snuffbox Approach.

Authors:  Yongcheol Kim; Myung Ho Jeong; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn
Journal:  Chonnam Med J       Date:  2019-01-25

4.  Feasibility of primary percutaneous coronary intervention via the distal radial approach in patients with ST-elevation myocardial infarction.

Authors:  Yongcheol Kim; Jun-Won Lee; Sang Yeub Lee; Jang-Whan Bae; Sang Jun Lee; Myung Ho Jeong; Seung-Hwan Lee; Youngkeun Ahn
Journal:  Korean J Intern Med       Date:  2020-03-03       Impact factor: 2.884
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.